A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490394 | PMC |
| http://dx.doi.org/10.3390/ph10020037 | DOI Listing |
Publication Analysis
Top Keywords
chronic pain
8
pain migraine
8
migraine review
8
development trpm8
4
trpm8 antagonists
4
antagonists treat
4
treat chronic
4
review development
4
development pharmaceutical
4
pharmaceutical antagonists
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!